Parvin Asset Management »

Immunitybio shares owned by Parvin Asset Management

Quarter-by-quarter ownership of Immunitybio (IBRX) shares owned by Parvin Asset Management from 13F filings

Historical chart of Parvin Asset Management investment in Immunitybio

Tip: Access up to 7 years of quarterly data

All positions including Immunitybio held by Parvin Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Immunitybio by Parvin Asset Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $307k 40k 7.67

More positions owned by Parvin Asset Management

Apple (AAPL)
Newmont Mining Corporation (NEM)
Agnico (AEM)
Coeur d'Alene Mines Corporation (CDE)
Hecla Mining Company (HL)
Endeavour Silver Corp (EXK)
State Street Global Advisors SPDR Trust S&p 500 $600 Exp 12/18/26 Put Put Option
Royal Gold (RGLD)
Osisko Gold Royalties (OR)
Silvercorp Metals (SVM)
Microsoft Corporation (MSFT)
Amgen (AMGN)
EOG Resources (EOG)
Kinross Gold Corp (KGC)
Raytheon Technologies Corp (RTX)

View all positions for Parvin Asset Management

Top funds holding Immunitybio

Vanguard Group
BlackRock
State Street Corporation
Vanguard Portfolio Management
Vanguard Capital Management
D. E. Shaw & Co
Geode Capital Management
Susquehanna International
Citadel Advisors
Two Sigma Investments
LMR Partners
Morgan Stanley
Hrt Financial
Woodline Partners
Goldman Sachs Group

View all funds holding Immunitybio